Cleveland BioLabs
CBLI
#10173
Rank
A$70.26 M
Marketcap
A$4.54
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -A$3.69 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are A$0.63 Million. In 2020 the company made an earning of -A$3.68 Million a decrease over its 2019 earnings that were of -A$3.39 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$3.69 Million0.12%
2020-A$3.68 Million8.8%
2019-A$3.39 Million-50.81%
2018-A$6.88 Million-14.3%
2017-A$8.03 Million-11.88%
2016-A$9.11 Million-50.9%
2015-A$18.54 Million-10.24%
2014-A$20.66 Million-37.5%
2013-A$33.05 Million-23.2%
2012-A$43.03 Million19.68%
2011-A$35.96 Million133.81%
2010-A$15.38 Million68.22%
2009-A$9.15 Million-55.51%
2008-A$20.55 Million-45.62%
2007-A$37.78 Million255.63%
2006-A$10.63 Million198.18%
2005-A$3.57 Million-1.25%
2004-A$3.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.60 B-573,529.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$44.57 B-1,130,865.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.01 B-330,229.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.96 B-278,331.17%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.74 B-348,757.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.33 B-363,812.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$16.76 Million 325.20%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.33 Billion 8,217.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA